Increment of High-Grade Gliomas Among Pediatric and Young Adult Population


  • Peer Asad Aziz Department of Neurosurgery, 1Bilawal Medical College
  • Muhammad Hamid Ali
  • Sanaullah Pathan
  • Mubarak Hussain
  • Suhail Ahmed Aghani
  • Riaz Ahmed Raja





Background/Objective:  Glioblastomas are among the commonest primary brain cancers. This study aimed to assess the trend shift of high-grade glioma in our setting among the young and pediatric population.

Materials and Methods:  This is a descriptive and cross-sectional study; it was carried out at the Department of Neurosurgery, Liaquat University of Medical and Health Sciences, between duration. All cases with suspected brain tumors, irrespective of age or gender were assessed for glioblastoma. Once a solid tumor was identified on imaging with consistent features of glioblastoma, a provisional diagnosis was established. After that, the patient underwent a brain biopsy. Patients' gender, demographics, clinical presentation, radiologic records, etc. were collected in a predefined proforma.

Results:  22 patients were diagnosed with glioblastoma with a high frequency of patients between the age range of 20 to 30 years. The most common location of the tumor was subcortical near the midline. There was slight male predominance. 8 patients had levels of KPS at presentation < 70 and among those two were infants, four were in a vegetative state, and two had a loss of consciousness secondary to increased intracranial pressure. The recurrence rate among those who came back for follow-ups was 27.2%.

Conclusion:  Though it is a short study with short follow-up results were astonishing due to perhaps trend shift among Glioblastoma patients, a further detailed workup is needed in different dimensions especially molecular level and genetics to know exactly about the disease and the national registry should be carried and alarmed to identify the problem at once, counter effectively and make a future strategy.


Lönn S, Klaeboe L, Hall P, Mathiesen T, Auvinen A, Christensen HC, Johansen C, Salminen T, Tynes T, Feychting M. Incidence trends of adult primary intracerebral tumors in four Nordic countries. International Journal of Cancer. 2004; 108 (3): 450-5.

Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'Yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008; 113 (S7): 1953-68.

Dobes M, Khurana VG, Shadbolt B, Jain S, Smith SF, Smee R, Dexter M, Cook R. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000–2008): findings of a multicenter Australian study. Surgical Neurology International. 2011; 2.

Tamimi AF, Juweid M. Epidemiology and outcome of glioblastoma. Exon Publications, 2017: 143-53.

Urba?ska K, Soko?owska J, Szmidt M, Sysa P. Glioblastoma multiforme–an overview. Contemporary Oncology. 2014; 18 (5): 307.

Chen B, Chen C, Zhang Y, Xu J. Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–2017. BMC Cancer. 2021; 21 (1): 1-0.

Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med. 2002; 21: 3511–26.

Mahvash M, Hugo HH, Maslehaty H, Mehdorn HM, Stark AM. Glioblastoma multiforme in children: report of 13 cases and review of the literature. Pediatr Neurol. 2011; 45: 178–80.

Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005; 109: 93–108.

Karnofsky DA, Burchenal JH. The evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed) Evaluation chemotherapy agents. Columbia University Press, New York, 1949: pp 191–205.

Glioblastoma Multiforme – Symptoms, Diagnosis and Treatment Options [Internet]. Aans.org2022 [cited 2022]; Available from:

Chakrabarti I, Cockburn M, Cozen W, Wang YP, Preston-Martin S. A population?based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2005; 104 (12): 2798-806.

Caroli E, Salvati M, Ferranate L. Spinal glioblastoma with brain relapse in child: Clinical considerations. Spinal Cord. 2005; 43: 565-68.

Russel DS, Rubinstein LJ. Pathology of tumors of the nervous system. London: Edward Arnold. 1989: 222.

Chen B, Chen C, Zhang Y, Xu J. Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–2017. BMC Cancer. 2021; 21 (1): 1-0.

Young JS, Chmura SJ, Wainwright DA, Yamini B, Peters KB, Lukas RV. Management of glioblastoma in elderly patients. Journal of the Neurological Sciences. 2017; 15; 380: 250-5.

Herrera-Oropeza GE, Angulo-Rojo C, Gástelum-López SA, Varela-Echavarría A, Hernández-Rosales M, Aviña-Padilla K. Glioblastoma multiforme: a multi-omics analysis of driver genes and tumour heterogeneity. Interface Focus. 2021; 11 (4): 20200072.

Leibetseder A, Ackerl M, Flechl B, Wöhrer A, Widhalm G, Dieckmann K, Kreinecker SS, Pichler J, Hainfellner J, Preusser M, Marosi C. Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO). Neuro-oncology. 2013; 15 (1): 112-21.

Nizamutdinov D, Stock EM, Dandashi JA, Vasquez EA, Mao Y, Dayawansa S, Zhang J, Wu E, Fonkem E, Huang JH. Prognostication of survival outcomes in patients diagnosed with glioblastoma. World Neurosurgery. 2018; 109: e67-74.

Yuile P, Dent O, Cook R, Biggs M, Little N. Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables. Journal of Clinical Neuroscienc. 2006; 13 (7): 747-51.

Chambless LB, Kistka HM, Parker SL, Hassam-Malani L, McGirt MJ, Thompson RC. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme. J Neurooncol. 2015; 121 (2): 359-64.